Results 21 to 30 of about 54,240 (219)

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

Periodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra, Hélène Rangé, Giuseppina Caligiuri, Philippe Bouchard   +3 more
wiley   +1 more source

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes [PDF]

New England Journal of Medicine, 2013
Although P2Y12 antagonists are effective in patients with non-ST-segment elevation (NSTE) acute coronary syndromes, the effect of the timing of administration--before or after coronary angiography--is not known. We evaluated the effect of administering the P2Y12 antagonist prasugrel at the time of diagnosis versus administering it after the coronary ...
Montalescot, G., Bolognese, L., Dudek, D., Goldstein, P., Hamm, C., Tanguay, J.F., Berg, J.M. van den, Miller, D.L., Costigan, T.M., Goedicke, J., Silvain, J., Angioli, P., Legutko, J., Niethammer, M., Motovska, Z., Jakubowski, J.A., Cayla, G., Visconti, L.O., Vicaut, E., Widimsky, P., Suryapranata, H., et al.   +21 more
openaire   +5 more sources

Characterisation of Patients with Acute Coronary Syndrome: A 10-Year Experience

European Medical Journal Cardiology, 2023
Introduction: Coronary intervention is a therapeutic method for acute coronary syndrome. Objectives: Characterise patients with acute coronary syndrome treated by percutaneous coronary intervention.
Andrew Sefenu Dzebu, Suilbert odríguez Blanco, Jose Manuel Aguilar Medina   +2 more
doaj   +1 more source

Biomarkers in acute coronary syndromes and their role in diabetic patients [PDF]

, 2005
Diabetic patients with acute coronary syndromes are at high risk for cardiovascular complications but risk stratification in these patients remains challenging.
Christopher Heeschen, Heeschen C, James SK, Khaliq A, Luttun A, Mak KH   +5 more
core   +1 more source

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]

, 2018
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M, Hirsh J, Ibanez B, Mega JL, Park KW, Suh JW, Valgimigli M   +6 more
core   +3 more sources

Non–ST-Segment Elevation Acute Coronary Syndromes [PDF]

Circulation: Cardiovascular Imaging, 2012
Non–ST-segment elevation (NSTE) acute coronary syndromes (ACS), encompassing NSTE myocardial infarction (NSTEMI) and unstable angina, lack the declarative electrocardiographic findings that readily identify patients with STEMI, yet comprise >70% of all ACS.1–3 Unlike STEMI patients who receive uniform treatment to restore flow in an occluded artery ...
Chang H, Min JK, Rao SV, Patel MR, Simonetti OP, AMBROSIO, Giuseppe, Raman SV   +6 more
openaire   +3 more sources

A case of de Winter syndrome presenting with chest tightness

Journal of International Medical Research, 2021
de Winter syndrome, also termed anterior ST-segment elevation myocardial infarction (STEMI) equivalent, is estimated to be present in approximately 2% of patients with acute myocardial infarction, but is often under-recognized by clinicians.
Dongmei Jiang, Guosheng Fu
doaj   +1 more source

Feasibility and performance of a device for automatic self-detection of symptomatic acute coronary artery occlusion in outpatients with coronary artery disease : a multicentre observational study [PDF]

, 2019
Background Time delay between onset of symptoms and seeking medical attention is a major determinant of mortality and morbidity in patients with acute coronary artery occlusion. Response time might be reduced by reliable self-detection.
Coeman, Mathieu, De Buyzere, Marc, De Pooter, Jan, Drieghe, Benny, Duytschaever, Mattias, El Haddad, Milad, Gevaert, Sofie, Gheeraert, Peter, Kayaert, Peter, Van Heuverswyn, Frederic, Vandekerckhove, Yves, Voet, Joeri   +11 more
core   +2 more sources

Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. [PDF]

, 2017
BackgroundElevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown.Methods and resultsBaseline demographics and 2-year MACE were ...
Ang, Lawrence, Behnamfar, Omid, Lin, Felice, Mahmud, Ehtisham, Palakodeti, Samhita, Patel, Mitul P, Pourdjabbar, Ali, Reeves, Ryan R   +7 more
core   +1 more source

The Year in Non–ST-Segment Elevation Acute Coronary Syndrome

Journal of the American College of Cardiology, 2005
Non-ST-segment elevation acute coronary syndrome (NSTE-ACS), which comprises unstable angina and non-ST-segment elevation myocardial infarction (NSTE-MI), accounted for approximately 1.7 million discharges (primary or secondary diagnoses) from U.S.
Giugliano, Robert P., Braunwald, Eugene
openaire   +9 more sources